期刊文献+

急性冠脉综合征患者介入术后慢血流事件与血浆D-二聚体水平关系 被引量:16

The relationship between plasma D-dimer and coronary slow flow in patients with acute coronary syndrome after percutaneous coronary intervention
原文传递
导出
摘要 目的:探讨急性冠脉综合征患者在接受介入治疗术时发生慢血流现象的危险因素及其与血浆D-二聚体水平的关系。方法回顾性分析行急诊PCI 的急性冠脉综合征患者297例。采用校正TIMI血流计帧法( cTFC)计算各支冠状动脉的TIMI帧数。根据术中cTFC结果将患者分为CSF组和冠脉血流正常对照组, Logistic回归方法分析CSF发生的临床危险因素。 ROC曲线分析D-二聚体水平对慢血流发生的预测价值。结果共计59例(19.8%)患者出现慢血流事件,血D-二聚体水平显著高于正常对照组(P<0.05)。 Logistic回归分析表明血D-二聚体水平(OR=1.276,95%CI:1.132-3.224, P =0.012)、罪犯血管的靶病变长度( OR =1.436,95%CI:0.635-1.382, P=0.037)、血栓负荷评分( OR=1.108,95%CI:1.085-2.103, P=0.018)是慢血流发生的独立危险因素。 ROC曲线表明血D-二聚体水平( ROC曲线下面积0.783, OR=1.502,95%CI:1.324-2.531, P=0.005)对慢血流的发生具有预测价值(敏感度为83.5%,特异度为69.1%)。结论 D-二聚体水平升高与急性冠脉综合征患者经皮冠状动脉介入治疗术后慢血流发生密切相关,有助于预测术中慢血流的发生。 Objective To study the correlation between the risk factors of coronary slow flow phenomenon ( CSF) and the level of plasma D-dimer in patients with ACS ( acute coronary syndrome) after emergency percutaneous coronary intervention ( PCI) .Methods A total of 297 patients with ACS after PCI were enrolled for retrospective analysis.All patients were divided into CSF group and control group in the light of corrected thrombolysis in myocardial infarction (TIMI) frame count method (cTFC).Multivariate analysis for evaluating clinical predictors of CSF was carried out using Logistic regression test and Pearson analysis to find the correlation between plasma D-dimer and cTFC.The predictive value of D-dimer level in the occurrence of coronary slow flow was determined by using receiver operating characteristic ( POC) curve analysis.Results CSF was observed in 59 cases (19.8%).The plasma D-dimer was significantly higher in the coronary slow flow group compared with the control group ( P 〈0.05 ) .Multivariate regression analysis and Logistic regression test showed that the level of plasma D-dimer ( OR =1.276, 95%CI:1.132-3.224, P=0.012), thrombus score (OR =1.108, 95%CI: 1.085-2.103, P =0.018) and target lesion length of culprit vessel ( OR =1.436, 95%CI: 0.635-1.382, P =0.037 ) were the risk factors of CSF.Correlation analysis showed that plasma D-dimer were positively associated with CSF. Receiver operating characteristic ( ROC ) curve analysis showed that D-dimer cutoff point at 515.3 ng/ml had a good judgment significance ( AUC 0.783, OR =1.502, 95%CI: 1.324-2.531, P =0.005). Conclusions The increased D-dimer level is a risk factor and plays an important role in the ACS patients with the CSF phenomenon, thereby predicting no-reflow phenomenon after primary PCI in these patients.
出处 《中华急诊医学杂志》 CAS CSCD 北大核心 2016年第4期475-478,共4页 Chinese Journal of Emergency Medicine
基金 国家自然科学基金(81573744) 北京市医院管理局临床医学发展专项经费资助(ZY201303) 国家临床重点专科建设项目(2013-2014) 北京市医院管理局登峰计划(DFL20150601)
关键词 血D二聚体 慢血流 急性冠脉综合征 经皮冠脉介入治疗 危险因素 预后 D-dimer Coronary slow flow Acute coronary syndrome Percutaneous coronary intervention Risk factors Prognosis
  • 相关文献

参考文献14

  • 1Gjin Ndrepepa. 5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction [J]. JACC, 2010, 55 (21) : 2283-2289. DOI: 10. 1016/jacc. 2009. 12. 054.
  • 2Kopetz VA, Penno MA, Hoffmann P, et al. Potential mechanisms of the acute coronary syndrome -presentation in patients with the coronary slow flow phenomenon insight from a plasma proteomic approach [J]. Int J Cardiol, 2012, 156 (1) : 84-91. DOI: 10. 1016/j. ijcard. 2011. 09014.
  • 3Niceoli G, Cosentino N, Spaziani C, et al. New strategies for the management of no-flow after prim- ary percutaneous coronary intervention [J]. Expert Rev Cardiovasc Ther, 2011, 9: 615- 630. DOI: 10. 1586/erc. 11. 49.
  • 4Sarli B, Akpek M, Baktir AO, et al. Impact of D-dimer level on postintervcntional coronary flow and in-hospital MACE in ST- segment elevation myocardial infarction [J]. Herz, 2014, 1: 1- 6. DOI: 10. 1007/s00059-013-4029-2.
  • 5Erkol A, Oduncu V, Turan B, et al. The value of plasma D-dimer level on admission in predicting no-reflow after primary percutaneous coronary intervention and long-term prognosis in patients with acute ST segment elevation myocardial infarction. J Thromb Thrombolysis, 2014, 38: 339-347. DOI: 10. 1007/s11239- 013-1044-3.
  • 6Movahed MR, Butman SM. The pathogenesis and treatment of noreflow occurring during precut- aneous coronary intervention [J]. Cardiovasc Revasc Med, 2008, 9: 56-61. DOI: 10. 1016/ j. carrev. 2007. 08. 005.
  • 7Burzotta F, Trani C, Romagnoli E, et al. Apilot study with an new rapid exchange, thrombus-aspi rating device in patientswith thrombus-containing lesions : the Diver C. E study [ J ]. Catheter Cardiovasc Interv, 2006, 67 (6): 887-893. DOI: 10. 1002/ ecd. 20713.
  • 8张伟,孙中华,米杰,罗欢,樊瑞娟,张春晓,齐向前.冠状动脉慢血流患者危险因素分析及临床随访[J].中华急诊医学杂志,2014,23(2):204-208. 被引量:21
  • 9Kirma C, Izgi A, Dundar C, et al. Clinical and procedural predictors of no -reflow phenomenon after primary percutaneous coronary interventions [J]. Circ J, 2008, 72: 716-721. 10. DOI. org/10. 1253/circj. 72. 716.
  • 10Statues HB, Patel AA, Stouffer GA. Optimal use platelet glycoprotein H b/, a receptor antagonists in patients undergoing percutaneous coronary interventions [J]. Drugs J, 2011, 71 ( 15 ) : 2009-2030. DOI: 10. 2165/11595010-000000000- 00000.

二级参考文献31

  • 1Romano M, Buffoli F, Tomasi L,et al. The no-reflow phenomenonin acute myocardial infarction after primary angioplasty: incidence,predictive factors, and long-term outcomes [J]. J Cardiovasc Med,2008, 9(1): 59-63.
  • 2Hale SL, MehraA, Leeka J, et al. Post conditioning fails toimprove no reflow or alter infarct size in an open-chest rabbit modelof myocardial ischemia-reperfusion [ J ]. Am J Physiol Heart CircPhysiol, 2008, 294 (1) : H421- H425.
  • 3Ohshima K, Ikeda S, Kadota H, et al. Cavity volume of rupturedplaque is an independent predictor for angiographic no-reflowphenomenon during primary angioplasty in patients with ST-segmentelevation myocardial infarction [ J ]. J Cardiol, 2011, 57 ( 1 ):3643.
  • 4Deibele AJ,Jennings LK,Tcheng JE,et al. Intracoronaryeptifibatide bolus administration during percutaneous coronaryrevascularization for acute coronary syndromes with evaluation ofplatelet glycoprotein Ilb/IIIa receptor occupancy and plateletfunction: the Intracoronary Eptifibatide ( ICE ) trial [ J ].Circulation, 2010, 121 (6): 784 -791.
  • 5Chen SM,Hsieh YK, Guo GB, et al. Angiographic and clinicaloutcome in ST-segment elevation myocardial infarction patientsreceiving an adjunctive double bolus regimen of tirofiban for primarypercutaneous coronary intervention [ J ]. Circ J,2006,70 (5 ):536-541.
  • 6Beltrame JF,Limaye SB,Horowitz JD.The coronary slow flow phenomenon-a new coronary microvascular disorder[J].Cardiology,2002,97 (4):197-202.
  • 7Tambe AA,Demany MA,Zimmerman HA,et al.Angina pectoris and slow flow velocity of dye in coronary arteries:a new angiographic finding[J].Am Heart J,1972,84 (1):66-71.
  • 8Mustafa Caliskan,Dogan Erdogan,Hakan Gullu,et al.Effects of atorvastatin on coronary flow reserve in patients with slow coronary flow[J].Clin Cardiol,2007,30 (9):475-479.
  • 9Mangieri E,Macchiarelli G,Ciavolella M,et al.Slow coronary flow:clinical and histopathological features inpatients with otherwise normal epicardial coronary arteries[J].CathetCardiovasc Diagn,1996,37 (4):375-381.
  • 10Li JJ,Wu YJ,Qin XW.Should slow coronary flow be considered as a coronary syndrome?[J].Medical Hypotheses,2006,66 (5):953-956.

共引文献40

同被引文献156

引证文献16

二级引证文献82

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部